A.I. Virtanen Institute for Molecular Sciences - News

Professor Tarja Malm’s research group takes part in a research project coordinated by the Finnish Red Cross Blood Service, with the aim of building models that accelerate and enhance Finnish medical research.

Professor Seppo Ylä-Herttuala has been invited as a Foreign Member to Class V: Medicine of the Polish Academy of Arts and Sciences.

Entrepreneurial skill-building, career transitions from academia to industry, and the future of research and innovation in neuroscience were key topics at Neurocenter Finland’s Annual Event.

The NOVEL MSCA Postdoctoral Programme offers interdisciplinary and intersectoral postdoctoral training in four key areas of brain health related research.

The Finnish Research Infrastructure Committee (FIRI Committee) has taken the funding decisions concerning the research infrastructures selected to Finland’s national roadmap.

The funding intends for the creation of clearly defined and tested business ideas that has business potential.

The goal of the study starting in January is to determine whether the new vaccine generates sufficient antibodies against the SARS-CoV-2 virus and its variants, and to ensure the vaccine’s safety.

The Research Council of Finland grants competitive funding to Finnish universities to support them in strengthening their research profiles.

Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia. This surprising finding may offer new avenues for screening and treatment.

Professor Katja Kanninen’s research group at the A. I. Virtanen Institute for Molecular Sciences is one of the partners in the new EU-funded MARKOPOLO project.